Gain Therapeutics Inc (GANX)

Nov 21, 2025

How Gain Therapeutics Inc. stock compares to industry benchmarksWeekly Profit Report & Expert Approved Trade Ideas - newser.com

Nov 21, 2025

Nov 20, 2025

Gain Therapeutics presents data on GT-02287 - TipRanks

Nov 20, 2025

Nov 20, 2025

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025 - The Manila Times

Nov 20, 2025

Nov 20, 2025

Gain Therapeutics (Nasdaq: GANX) Reports GT-02287 Mitochondrial, Neuronal Data - Stock Titan

Nov 20, 2025

Nov 20, 2025

Will Gain Therapeutics Inc. stock deliver strong dividend growthInsider Buying & Real-Time Volume Analysis Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Gain Therapeutics Inc. stock outlook for YEARJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Gain Therapeutics Inc. stock ready for a breakoutWeekly Trade Recap & Weekly Breakout Watchlists - newser.com

Nov 19, 2025

Nov 19, 2025

Can machine learning forecast Gain Therapeutics Inc. recovery2025 Performance Recap & Fast Momentum Entry Tips - newser.com

Nov 19, 2025

Nov 17, 2025

Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know - sharewise.com

Nov 17, 2025

Nov 17, 2025

How does Gain Therapeutics Inc (GANX) change from a tortoise to a hare? - Setenews

Nov 17, 2025

Nov 17, 2025

Is Gain Therapeutics Inc. stock undervalued vs historical averagesQuarterly Market Summary & Consistent Growth Stock Picks - newser.com

Nov 17, 2025

Nov 17, 2025

Equities Analysts Set Expectations for GANX FY2025 Earnings - Defense World

Nov 17, 2025

Nov 17, 2025

Will Gain Therapeutics Inc. stock go up soon2025 Price Targets & AI Enhanced Trading Signals - newser.com

Nov 17, 2025

Nov 16, 2025

Can Gain Therapeutics Inc. stock deliver sustainable ROEWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Why Gain Therapeutics Inc. stock remains on buy listsJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025

Nov 15, 2025

Is Gain Therapeutics Inc. stock a buy before product launchesMarket Trend Review & Safe Capital Preservation Plans - newser.com

Nov 15, 2025

Nov 15, 2025

Building trade automation scripts for Gain Therapeutics Inc.Weekly Trading Summary & Verified Momentum Watchlists - newser.com

Nov 15, 2025

Nov 13, 2025

Gain Therapeutics Reports Continued Progress Amid Financial Challenges - The Globe and Mail

Nov 13, 2025

Nov 13, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Nov 13, 2025

Nov 13, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Nov 13, 2025

Nov 13, 2025

Day 6 of Gains Streak for Gain Therapeutics Stock with 78% Return (vs. 37% YTD) [11/12/2025] - Trefis

Nov 13, 2025

Nov 12, 2025

[8-K] Gain Therapeutics, Inc. Reports Material Event | GANX SEC FilingForm 8-K - Stock Titan

Nov 12, 2025

Nov 12, 2025

[10-Q] Gain Therapeutics, Inc. Quarterly Earnings Report | GANX SEC FilingForm 10-Q - Stock Titan

Nov 12, 2025

Nov 12, 2025

Gain Therapeutics reports Q3 EPS (15c), consensus (15c) - TipRanks

Nov 12, 2025

Nov 12, 2025

Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update - The Manila Times

Nov 12, 2025

Nov 12, 2025

Gain Therapeutics (NASDAQ: GANX) completes Phase 1b enrollment of 21; extension approved - Stock Titan

Nov 12, 2025

Nov 12, 2025

Sentiment analysis tools applied to Gain Therapeutics Inc.Weekly Market Report & Free High Return Stock Watch Alerts - newser.com

Nov 12, 2025

Nov 11, 2025

Advanced analytics toolkit walkthrough for Gain Therapeutics Inc.Quarterly Profit Summary & Weekly High Return Forecasts - newser.com

Nov 11, 2025